Abstract
Objective: To investigate whether prognosis of breast-, colon- and prostate cancer may be related to vitamin D3, induced from solar ultra-violet (UV) radiation, through studies on geographical and seasonal variations in UV radiation. Methods: This study includes 115,096 cases of breast-, colon- or prostate cancer, diagnosed between 1964 and 1992. Among these, 45,667 deaths due to the cancer were registered. On the basis of a north–south gradient in solar UV radiation and geographical climatic differences, Norway was divided into eight residential regions. According to seasonal variations in UV radiation, four periods of diagnosis during the year were used. Case fatality according to residential region and to season of diagnosis was estimated using Cox regression. The effects of occupational sun exposure, childbearing pattern and educational level were also evaluated. Results: No geographic variation in case fatality was observed for the three cancer types studied. A significant variation in prognosis by season of diagnosis was observed. Diagnoses during summer and fall, the seasons with the highest level of vitamin D3, revealed the lowest risk of cancer death. Conclusion: The results suggest that a high level of vitamin D3 at the time of diagnosis, and thus, during cancer treatment, may improve prognosis of the three cancer types studied.
Similar content being viewed by others
References
Abe E, Miyaura C, Sakagimi H, et al. (1981) Differentiation of mouse myeloid leukemia cells induced by 1,25(OH)2 vitamin D3. Proc Nat Acad Sci 78: 4990-4994.
Danielsson C (1998) Molecular Mechanism of Cell Regulatory Properties of Vitamin D Analogues in Human Cancer Cells Lines. Sweden: Acta Univercitas Upsaliensis.
Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF (1979) Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188-1190.
Mehta RG, Mehta RR (2002) Vitamin D and cancer. J Nutr Biochem 13: 252-264.
Buras R, Schumaker LM, Davoodi F, et al. (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191-202.
Cross HS, Bajna E, Bises G, et al. (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 16: 2333-2338.
El Abdaimi K, Dion N, Papavasiliou V, et al. (2000) The vitamin D analougue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res 60: 4412-4418.
Mantell DJ, Owens PE, Bundred NJ, et al. (2000) 1,25-dihydroxyvitamin D (3) inhibits angiogenesis in vitro and in vivo. Circ Res 87: 214-220.
Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M (2001) 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Comm 285: 1012-1017.
Lamprecht SA, Lipkin M (2001) Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann NY Acad Sci 952: 73-87.
Sundaram S, Sea A, Feldman S, et al. (2003) The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 9: 2350-2356.
Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622.
Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19: 820-824.
John EM, Schwarts GG, Dreon DM, Koo J (1999) Vitamin D and breast cancer risk: the NHANES I Epidemiological follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomark Prev 8: 399-406.
Freedman DM, Dosemeci M, McGlynn K (2002) Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 59: 257-262.
Grant WB (2002) An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875.
Grant WB (2002) An ecological study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94: 272-281.
Garland C, Barrett-Connor E, Rossof AH, Shekelle RB, Criqui MH, Paul O (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 9: 307-309.
Martinez ME, Willett WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7: 163-168.
Schwartz GG, Hulka BS (1990) Is vitamin D defiance a risk factor for prostate cancer? (hypothesis). Anticancer Res 10: 1307-1311.
Schwartz GG, Wang MH, Zhang M, Singh RK, Siegal GP (1997) 1a,25-Dihydroxyvitamin D (Calcitriol) inhibits the invasiveness of human prostate cancer cell. Cancer Epidemiol Biomark Prev 6: 727-732.
Luscombe CL, Fryer AA, French ME, et al. (2001) Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358: 641-642.
McLaughlin JA, Anderson RR, Holick MF (1982) Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216: 1001-1003.
McLaughlin M, Raggat PR, Faimey A, Brown DJ, Lester E, Wills MR (1974) Seasonal variation in serum 25-hydroxycholecalciferol in healthy people. Lancet (i) 536-540.
Stamp TCB, Round JM (1974) Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247: 563-569.
Lund B, Sørensen OH (1979) Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin-D intake in the Danish population. Scand J Clin Lab Invest 39: 23-30.
Poskitt EME, Cole TJ, Lawson DEM (1979) Diet, sunlight and 25-hydroxyvitamin D in healthy children and adults. Br Med J 1: 221-223.
Vik T, Try K, Strømme JH (1980) The vitamin D status of man at 70° north. Scand J Clin Lab Invest 40: 227-232.
McKenna KJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93: 69-77.
Holick MF, McCollum C (1994) Award lectures. Vitamin D: new horizons for the 21st century. Am J Clin Nutr 60: 619-630.
Moan J, Dahlback A, Henriksen T, Magnus K (1989) Biological amplification factor for sunlight-induced nonmelanoma skin cancer at high latitudes. Cancer Res 49: 5207-5212.
Dahlback A (1996) Measurements of biologically effective UV doses, total ozone abundances, and cloud effects with multichannel, moderate bandwidth filter instruments. Appl Opt 35: 6514-6521.
International Labour O.ce, ILO(1962) International Standard Classification of Occupations 1958. Genova: ILO.
Norusis MJ (2001) SPSS for Windows, Base System User's Guide Release 11.0. Chicago, Illinois: SPSS Inc.
Van der Wielen RPJ, Lowik MRH, Van den Berg H, et al. (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207-210.
Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL (1992) Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1, 25-Dihydroxyvitamin D3 and intestinal Vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 75: 176-182.
Johnsen B, Mikkelborg O, Hannevik M, Nilsen LT, Saxebøl G, Blaasaas KG (2002) The Norwegian UV-monitoring program, period 1995/96 to 2001. Østerås: Norwegian Radiation Protection Authority.
Webb AR, Holick MF (1988) The role of sunlight in the cutaneous production of vitamin D3. Ann Rev Nutr 8: 375-399.
The National Council of Nutrition and Physical Activity, NCNPA(1982) Kostholdsmessig Analyse av Matvarekjøp hos Grupper av Privathusholdninger 1977-1979. Oslo: Statistics Norway.
Janowsky EC, Lester GE, Weinberg CR, et al. (1999) Association between low levels of 1,25-dihydroxyvitamin D and breast cancer. Pub Health Nutr 2: 283-291.
Gunter E, Looker A, Lavoie D, Twite D, Calvo M (1997) 25-OHvitamin D levels in the United States population: NHANES III (1988-1994). In: Norman AW, Bouillon R, Thomasset M, eds. Riverside, CA: University of California, pp. 709-710.
Cross HS, Kallay E, Farhan H, Weiland T, Manhardt T (2003) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Cancer Res 164: 413-425.
Rachez C, Freedman LP (2000) Mechanisms of gene regulation by vitamin D3 receptor: a network of coactivator interactions. Gene 246: 9-21.
Hofer H, HO G-M, Peterlik M, et al. (1999) Biological effects of 1a-hydroxy-and 1b-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. J Pharma Exper Therap 291: 450-455.
Deluca HF, Cantora MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15: 2579-2585.
Kravdal Ø (1999) Social inequalities in cancer survival. Tidskr Nor Lægeforen 119: 1577-1583.
The National Council on Nutrition and Physical Activity, NCNPA(1989) Rapport om Vitamin D Inntak og Vitamin D Status i den Norske Befolkning. Oslo: NCNPA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robsahm, T.E., Tretli, S., Dahlback, A. et al. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 15, 149–158 (2004). https://doi.org/10.1023/B:CACO.0000019494.34403.09
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000019494.34403.09